Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 4Unknown 2Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4

Conditions

Multiple Myeloma 4Smoldering Multiple Myeloma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm, Residual 1Neoplasm Metastasis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Promyelocytic, Acute 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Dexamethasone 363Bortezomib 232Lenalidomide 202Cyclophosphamide 174Melphalan 154Calcium Dobesilate 107Peripheral Blood Stem Cell Transplantation 92fludarabine phosphate 84Thalidomide 81Filgrastim 71carfilzomib 68pomalidomide 66Granulocyte Colony-Stimulating Factor 60Mycophenolic Acid 59Busulfan 57daratumumab 55Whole-Body Irradiation 54Tacrolimus 51ixazomib 50Prednisone 50Cyclosporine 49fludarabine 46Antilymphocyte Serum 35Etoposide 30dexamethasone acetate 29Methotrexate 29plerixafor 27Radiotherapy 26Doxorubicin 26dexamethasone 21-phosphate 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Multiple Myeloma × Maintenance × Clear all
NCT00777998 2023-10-27

Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma

Universitätsklinikum Hamburg-Eppendorf

Phase 2 Completed
221 enrolled
Plasma cell

Multiple Myeloma

NCT00580372 2016-09-20

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma

University of Arkansas

Phase 2 Completed
231 enrolled 6 charts
Plasma cell

Multiple Myeloma

NCT00480363 2013-07-31

QUIREDEX

PETHEMA Foundation

Phase 3 Completed
120 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT00560053 2008-11-27

Pethema Multiple Myeloma 2000

PETHEMA Foundation

Phase 3 Completed
500 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡